Skip to main navigation
Skip to search
Skip to main content
Keio University Home
Help & FAQ
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach?
Yusuke Kobayashi
, Kouji Banno
, Haruko Kunitomi
, Shimpei Nagai
, Takayuki Takahashi
, Mayuka Anko
, Moito Iijima
, Takashi Takeda
, Yusuke Matoba
,
Kanako Nakamura
, Kosuke Tsuji
, Eiichiro Tominaga
, Daisuke Aoki
Department of Obstetrics and Gynecology (Gynecology)
Department of Obstetrics and Gynecology
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
25%
Breast Cancer
25%
Clinical Trial
25%
Colorectal Cancer
25%
Coronary Artery Disease
25%
Disease
25%
Drug Antibody
25%
Drug Development
25%
Drug Repositioning
100%
Dyslipidemia
25%
Endometrium Cancer
25%
Heart Arrhythmia
25%
Heart Failure
25%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
75%
Immune Checkpoint Inhibitor
25%
Malignant Neoplasm
100%
Mevalonic Acid
25%
Neoplasm
25%
Ovary Cancer
25%
Pharmacotherapy
25%
Prostate Cancer
25%
Protein P53
25%
Statin (Protein)
100%
Uterine Cervix Cancer
25%
Keyphrases
Drug Antibodies
33%
Medicine and Dentistry
Drug Antibody
25%